Skip to content

Efficacy and Safety of Low-Level Light Therapy in Tinnitus

Efficacy and Safety of Low-Level Light Therapy in the Management of Cochlear Tinnitus: A Single-blind, Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0002898
Enrollment
40
Registered
2018-05-28
Start date
2017-03-14
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Procedure/Surgery : Before intervention&gt
? Before the intervention, check the side of intervention and sterilize the external ear. &lt
intervention procedures&gt
? The subject will receive the intervention in a quiet room and will be able to listen to quiet music to mask the laser sound. ? The subject and physician wear the laser protective goggles. ? The p
Procedures and precautions after intervention &gt
? If no adverse effects have occurred or the appropriate action is taken for the adverse effect after the intervention, the physician educates the subject about the remedial action. ? Laser irradiati

Sponsors

Dankook Univeristy Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged = 19 years 2. Unilateral subjective tinnitus symptoms for more than 3 months (If the subject has bilateral tinnitus, subject who has dominant symptom between two ears could be enrolled.) 3. Averaged hearing thresholds > 15 dB at 3000, 4000, or 6000 Hz 4. Subject who did not take any medication for tinnitus one month before enrollment 5. Consent to and willing to discontinue medication for tinnitus (eg, Ginkgo-Biloba, Tanamin, etc.) during this trial 6. Women of childbearing age who are confirmed by negative in pregnancy test and who agree to use the contraceptive device during the study 7. Those who agree not to receive any treatment on the ear during the period of clinical trial participation 8. Those who voluntarily participate in the trial and are willing to follow the protocol 9. Those who have fully understood the written consensus

Exclusion criteria

Exclusion criteria: 1. In the cases that the tinnitus has definite cuase (acoustic neurinoma, cerebral tumor, cerebral vessel malformation, vascular tinnitus, tinnitus induced by muscle contraction) 2. Those with history of conductive hearing loss, perforation of the eardrum, etc. 3. Experiences of ototoxic drugs, those who have had meningitis 4. Those who have ear diseases such as external otitis, ear canal occlusion, otitis media 5. Any person who has had a serious disease in cardiovascular, digestive, respiratory, endocrine, or central nervous system, or a mental illness 6. Anyone who is sensitive to light 7. Women of childbearing age who do not agree to contraception during the study

Design outcomes

Primary

MeasureTime frame
numerical rating scale for loduness, duration, annoyance;THI (Tinnitus Handicap Inventory) Questionnaire;tinnitogram (loudness, MML);Safety

Secondary

MeasureTime frame
tinnitogram (pitch)

Countries

Korea, Republic of

Contacts

Public ContactJi Eun

Dankook Univeristy Hospital

garimung@gmail.com+82-43-550-7466

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026